News

The US Food and Drug Administration announced on August 7, 2025, FDA PreCheck, which is a new program in order to strengthen the domestic pharmaceutical supply chain by way of increasing regulatory productivity along with facilitating the construction of...

Aurobindo acquires Lannett – the US Drugmaker for $250 million thereby shoring up the Indian drugmaker's footprint in the US in the middle of the threats that the Trump administration plans so as to impose tariffs when it comes...

The medicine manufacturers from Europe are bracing for President Donald Trump’s plan to slap tariffs of almost 250% on medicine imported from the EU. The declaration made by Trump that the drug exports of Europe will be hit with certain...

The lawmakers in Washington have shared the angst of US drugmakers, which have been surpassed by the fast-progressing biotechnology sector of China, but have not raised any alarms on the recent surge within the licensing deals for medicines that...

Grief is a deeply personal and often overwhelming experience. When we lose someone we love, the pain can feel insurmountable. But amid sorrow, many people find strength and purpose by channelling their grief into meaningful action. Whether it's to...

Pain after an accident can be overwhelming and can affect every part of life. Injuries can make moving, resting, and handling everyday tasks hard. Getting treatment quickly is important to avoid long-term discomfort and additional complications. A provider network...

Incorporating early regulatory planning in product development can significantly reduce costs and enhance efficiency. Collaborating with regulatory experts ensures thorough evaluations and strategic planning, optimizing resources and streamlining manufacturing processes. The medical device industry faces numerous regulatory challenges that can...